Listing #8183369 novocure.com
308
Novocure (NASDAQ: NVCR) is an oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields.
Category
Website Performance
| observedFirstContentfulPaintAllFrames | 1.84 Sec |
| observedCumulativeLayoutShift | 0 Sec |
| totalCumulativeLayoutShift | 0 Sec |
| observedLoad | 1.86 Sec |
| observedFirstContentfulPaint | 1.84 Sec |
| observedNavigationStart | 0 Sec |
| observedFirstVisualChangeTs | 782144312633 |
| observedSpeedIndex | 1.82 Sec |
| observedLargestContentfulPaintAllFramesTs | 782144451968 |
| observedLastVisualChangeTs | 782144645633 |
| interactive | 1.74 Sec |
| largestContentfulPaint | 1.77 Sec |
| firstMeaningfulPaint | 1.29 Sec |
| observedLargestContentfulPaintAllFrames | 1.84 Sec |
| totalBlockingTime | 0.03 Sec |
| observedFirstContentfulPaintTs | 782144451968 |
| observedFirstContentfulPaintAllFramesTs | 782144451968 |
| firstContentfulPaint | 0.99 Sec |
| cumulativeLayoutShiftMainFrame | 0 Sec |
| observedDomContentLoadedTs | 782143984547 |
| observedFirstMeaningfulPaintTs | 782144451968 |
| observedTraceEnd | 4.19 Sec |
| observedTimeOrigin | 0 Sec |
| observedFirstPaintTs | 782143789196 |
| observedTimeOriginTs | 782142612633 |
| observedSpeedIndexTs | 782144432471 |
| observedLoadTs | 782144474074 |
| observedDomContentLoaded | 1.37 Sec |
| speedIndex | 1.9 Sec |
| observedFirstPaint | 1.18 Sec |
| observedLargestContentfulPaintTs | 782144451968 |
| observedNavigationStartTs | 782142612633 |
| observedFirstMeaningfulPaint | 1.84 Sec |
| observedLargestContentfulPaint | 1.84 Sec |
| observedCumulativeLayoutShiftMainFrame | 0 Sec |
| observedTotalCumulativeLayoutShift | 0 Sec |
| cumulativeLayoutShift | 0 Sec |
| observedLastVisualChange | 2.03 Sec |
| observedTraceEndTs | 782146799172 |
| maxPotentialFID | 0.08 Sec |
| observedFirstVisualChange | 1.7 Sec |
